Skip To Main Content
Skip To Navigation
Contact Us
Twitter
Facebook
RSS Feed
Inflection Biosciences
Unsubscribe
Email
Inflection Biosciences Announces Publication of Positive Data for Dual Mechanism Inhibitor Against Chronic Lymphocytic Leukaemia
Tuesday, 17 July 2018
Inflection Biosciences and Trinity College Dublin Announce Immuno-Oncology Research Collaboration
Monday, 16 April 2018
Inflection Biosciences Announces Presentation at the 2018 American Association for Cancer Research Annual Meeting
Friday, 13 April 2018
RSS Feed
More News
Home
About Us
Leadership
Board of Directors
Advisors
Careers
Research
Cancer
Pipeline
Dual Mechanism Kinase Inhibitors
Pim Kinase Inhibitors
Partnering
In-licensing
Out-licensing
News
Press Releases
In the News
Search
Search - Use spaces to separate your keywords
Search
© 2018 Inflection Biosciences
.
Web Design
by Webtrade
Disclaimer
Privacy Policy
Copyright
Site map